Achillion Pharmaceuticals Inc $9.79

down -0.08


20/8/2014 04:00 PM  |  NASDAQ : ACHN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ACHN Trend Analysis - it has outperformed the S&P 500 by 24%

Partner Headlines

  1. ACHILLION PHARMA

    IBD
  2. UPDATE: Achillion Has Received US Patent for ACH-3102, Structurally-Related ...

    Benzinga
  3. Achillion Pharmaceuticals

    IBD
  4. Achillion Pharmaceuticals Up On Buyout Rumors

    IBD
  5. Dow Surges 175 Points; Fabrinet Shares Slide

    Benzinga
  6. Markets Open Higher; Dollar General Offers $9.7 Billon To Buy Family Dollar

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Deutsche Bank Raises Achillion Price Target 183%

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. Gilead Wins Sovaldi Ruling

    IBD
  11. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  12. Markets Close The Week On Negative Note As Ukraine Worries Mount

    Benzinga
  13. U.S. Stocks Turn Lower; Dillard's Shares Slide On Downbeat Earnings

    Benzinga
  14. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  15. Markets Gain; J.C. Penney Posts Narrower-Than-Expected Q2 Loss

    Benzinga
  16. Stocks Hitting 52-Week Highs

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Morning Market Movers

    Benzinga
  20. Benzinga's Top Upgrades

    Benzinga
  21. Piper Jaffray Upgrades Achillion Pharmaceuticals To Overweight

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline

    Benzinga
  24. Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly

    Benzinga
  25. Achillion

    IBD
  26. Achillion Could Win Idenix's Mystery Suitor: Analyst

    IBD
  27. Baird Comments On Achillion's Bullish Share Action

    Benzinga
  28. Benzinga's Top #PreMarket Losers

    Benzinga
  29. Benzinga's Top #PreMarket Losers

    Benzinga
  30. Achillion Gets Massive Price Target Hike On HCV Drugs

    IBD
  31. Achillion gets price target hike

    IBD
  32. Mid-Day Market Movers For Monday, June 16, 2014

    Benzinga
  33. Achillion Gets Massive Price Target Hike On HCV Drugs

    IBD
  34. Morning Market Movers

    Benzinga
  35. Maxim Group Significantly Raises Achillion's PT, Shares Soar +15%

    Benzinga
  36. Mid-Afternoon Market Update: Markets Reverse Early Loses; Oil Continues ...

    Benzinga
  37. Mid-Morning Market Update: Markets Mostly Flat; Priceline To Acquire OpenTable ...

    Benzinga
  38. Morning Market Losers

    Benzinga
  39. Benzinga's Top #PreMarket Losers

    Benzinga
  40. Benzinga's Top Upgrades

    Benzinga
  41. FDA lifts hold, Achillion soars

    IBD
  42. Mid-Afternoon Market Update; RadioShack Misses More Than Expected, BE Aerospace ...

    Benzinga
  43. Mid-Day Market Update: Francesca's Falls On Downbeat Results; Achillion ...

    Benzinga
  44. Achillion Forges Ahead With Hep C Program On FDA OK

    IBD
  45. Mid-Morning Market Update: Markets Open Lower; RadioShack Reports Wider ...

    Benzinga
  46. Morning Market Movers

    Benzinga
  47. Benzinga's Top #PreMarket Gainers

    Benzinga
  48. Top Healthcare Movers For June 9, 2014

    Benzinga
  49. Morning Market Movers

    Benzinga
  50. Hepatitis C Stocks Move After Idenix Rockets Up 235%

    Benzinga
Trading Center